Novavax, Inc. (NVAX) PT Increased as B. Riley Sees Governance-Driven Catalysts Ahead

TheFly reported connected April 9 that B. Riley Financial accrued its terms people connected NVAX from $16 to $18 portion maintaining a Buy rating. The update reflected expectations that ongoing shareholder activism focused connected governance and outgo operation could pb to changes successful committee creation and further improvements to the company’s equilibrium sheet.

Separately, connected April 18, Sanofi and Novavax, Inc. (NASDAQ:NVAX) reported results from the COMPARE Phase 4 objective trial, the archetypal nonstop head-to-head survey assessing tolerability betwixt protein-based Nuvaxovid and an mRNA COVID-19 vaccine, mNEXSPIKE developed by Moderna. The randomized, double-blind survey demonstrated that Nuvaxovid produced importantly little systemic reactogenicity crossed each cardinal measured outcomes, indicating less expected post-vaccination broadside effects compared with the comparator vaccine.

Findings were presented astatine a large infectious illness league successful Munich, Germany. The results reenforce the established information and tolerability illustration of Nuvaxovid and are intended to enactment broader assurance successful the vaccine. They besides align with ongoing commercialization efforts led by Sanofi for the upcoming vaccination season, with the information perchance contributing to improved nationalist acceptance and uptake of protein-based COVID-19 vaccination options.

Novavax, Inc. (NASDAQ:NVAX) is simply a biotechnology institution based successful Maryland that develops vaccines for infectious diseases. It uses recombinant macromolecule nanoparticle exertion and its Matrix-M adjuvant to heighten immune response.

While we admit the imaginable of NVAX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: Top 10 AI-Powered Biotech Stocks to Buy Right Now and 10 Most Undervalued Dow Stocks to Buy Now.

Disclosure: None. Follow Insider Monkey connected Google News.